A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8164-8170

  Chun, Young Jin ^a   Kim, Sanghee ^b   Kim, Donghak ^c   Lee, Sang Kwang ^a   Guengerich, F Peter ^c  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4,3'5' TETRAMETHOXYSTILBENE; ACETYLCYSTEINE; CYTOCHROME P450 INHIBITOR; DITHIOTHREITOL; ESTRADIOL; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE; HISTIDINE; RHAPONTIGENIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL MEMBRANE; BREAST CARCINOGENESIS; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; GENOTOXICITY; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; LIVER MICROSOME; METABOLIC ACTIVATION; MUTAGENESIS; PRIORITY JOURNAL; STEROIDOGENESIS;

ANIMALS; ANTIMUTAGENIC AGENTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; KINETICS; MICROSOMES, LIVER; RABBITS; RECOMBINANT PROTEINS; STILBENES; SUBSTRATE SPECIFICITY;

EID: 0035890772     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Activation of chemically diversed procarcinogens by human cytochrome P-450 1B1
2. Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s
3. Dose-response relationship of cytochrome P4501B1 mRNA induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in livers of C57BL/6J and DBA/2J mice
4. Different response of 2,3,7,8-tetrachlorodibenzop-dioxin (TCDD)-sensitive genes in human breast cancer MCF-7 and MDA-MB231 cells
5. 17 β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1
6. Catalytic properties of polymorphic human cytochrome P450 1B1 variants
7. Estrogen carcinogenesis in Syrian hamster tissues: Role of metabolism
8. Carcinogenicity of catechol estrogens in Syrian hamsters
9. Resveratrol is a selective human cytochrome P450 1A1 inhibitor
10. Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin
11. Crown ether catalyzed stereospecific synthesis of Z- and E-stilbenes by Wittig reaction in a solid-liquid two-phase system
12. Synthesis of higher oxidized metabolites of dibenz[a, j]anthracene implicated in the mechanism of carcinogenesis
13. The antifungal agent from Osage Orange wood
14. Natural stilbenes: Synthesis of polyhydroxystilbene ethers with the Wittig reaction
15. Drug metabolism by Escherichia coli expressing human cytochromes P450
16. Purification of functional recombinant P450s from bacteria
17. Analysis and characterization of enzymes
18. Cytochrome P450 1B1 (P450 1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity
19. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450
20. Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes
21. Polymorphisms in P450 P450 [B] affect the conversion of estradiol to the potentially carcinogenic metabolite 4-hydroxyestradiol
22. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli
23. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties
24. Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane
25. Elucidation of distinct ligand binding sites for cytochrome P450 3A4
26. The Escherichia coli lacZ reversion mutagenicity assay
27. 4-Hydroxylation of estrogens as marker of human mammary tumors
28. Dual role of oestrogens as hormones and pro-carcinogens: Tumor initiation by metabolic activation of oestrogens
29. Expression of cytochrome P450 1B1 in breast cancer
30. Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1
31. Effect of 2,4,3′,5′-tetrahydroxystilbene on oxidative phosphorylation by rat liver mitochondria
32. Inhibition of mitochondrial ATPase by 2,4,3′,5′-tetrahydroxystilbene
33. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1
34. Human P450 1B1 and anticancer agent metabolism: Mechanism for tumor-specific drug inactivation?
35. Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 P450 1A and P450 1B1